- Konuralp Tıp Dergisi
- Volume:16 Issue:1
- Exploring Perspectives on Cancer Screening in People Aged 30-70: A Comparative Study of Those With a...
Exploring Perspectives on Cancer Screening in People Aged 30-70: A Comparative Study of Those With and Without Type 2 Diabetes
Authors : Yunus Gür, Egemen Tural, Akın Dayan
Pages : 26-31
Doi:10.18521/ktd.1392977
View : 108 | Download : 187
Publication Date : 2024-03-14
Article Type : Research Paper
Abstract :Objective: The aim of the study was to assess attitudes and behaviors related to cancer screening using an attitude scale for cancer screening among individuals aged 30-70 with and without type 2 diabetes mellitus. Methods: This prospective case-control study was conducted from March to May 2023 at a single center. A total of 197 participants, including 67 patients with type 2 diabetes mellitus and 130 participants without type 2 diabetes mellitus aged 30-70, were enrolled using simple random sampling. For the assessment, a sociodemographic form prepared through a literature review and the attitude scale for cancer screening were used. A statistical significance level of p<0.05 was considered. Results: The study participants had an average age of 49.65±12.49 years. The attitude scale for cancer screening scores did not show a statistically significant difference between individuals with and without type 2 diabetes mellitus (z=1.485,p=0.138). Furthermore, the statistical analysis did not identify a significant difference with the total score of the attitude scale for cancer screenings among other variables. Positive correlation was found between the attitude scale for cancer screening total score and age (rho= 0.206, p=0.004). Conclusion: In our study, statistically significant differences in attitudes and behaviors towards cancer screenings were not observed between individuals with and without type 2 diabetes mellitus. However, it is essential to be attentive to the elevated risk of cancer in patients with type 2 diabetes mellitus. Therefore, increasing awareness and screening rates for cancer in this group is crucial.Keywords : Diyabetes Mellitus Tip 2, Tanı, Kanserin Erken Tespiti, Hiperglisemi